Biomarkers Discovery and Development Congress

Venue: The Midlands Hotel

Location: Manchester, United Kingdom

Event Date/Time: Feb 26, 2007 End Date/Time: Feb 27, 2007
Registration Date: Feb 15, 2007
Early Registration Date: Sep 29, 2006
Report as Spam


The Biomarkers Development and Discovery Congress focuses upon how the application of technology, experimental medicine and diagnostics can be implemented alongside the constraints of safety and containing toxicity, to achieve a successful business case scenario and the discovery of genuine biomarkers. Oxford international offers attendees a unique opportunity to network with senior-level R&D executives in the biomarkers sector from the major pharma and biotech companies.

Throughout the two day event, conference programme will address key issues including;

Current and future business models: Biomarkers as a means of empowering decision-making, reducing costs and increasing ROI
Imaging Technologies: Integration of biomarker Imaging techniques from pre-clinical to clinical
Regulation: Biomarkers as surrogate endpoints and ways of linking therapeutic approaches to diagnostics
Biomarkers for Molecular Diagnostics: Translation from Discovery to the Clinic
Efficacy models: Application of safety and efficacy biomarkers to personalised medicine and specific therapeutic areas
Toxicity biomarkers: safety, validation and efficacy testing

Application of Clinical Biomarkers: Validation of biomarkers to optimize early clinical development in and Incorporating Biomarker analyses into early clinical trials

The Biomarkers Discovery and Development Congress will take place on the 26th-27th February 2007 at The Midland Hotel, Manchester, UK.


Peter Street,
United Kingdom